Montreal, Québec, July 19th, 2007 – Aptilon Corporation (TSX VENTURE:APZ) ("Aptilon" or the "Corporation") announced today that it has completed a public offering of Common Shares pursuant to which the Corporation issued to investors 25,000,000 Common Shares at a price of $0.40 per Common Share, for aggregate gross proceeds of $10,000,000. Aptilon expects to use the proceeds of the Offering for working capital and for general corporate purposes, including acquisitions. The Company has no present agreements or commitments with respect to any acquisitions.
Paradigm Capital Inc., as lead agent, Loewen, Ondaatje, McCutcheon Limited. and Cormark Securities Inc. acted as agents in respect of this offering of Common Shares. For their services, the agents received a commission of $650,000 and were issued 1,125,000 compensation warrants, each compensation warrant entitling the holder to acquire one Common Share at a price of $0.40 until January 19, 2009.
The agents have been granted an over-allotment option for a period of 30 days following the closing of the offering to arrange for the sale of up to an additional 3,750,000 common shares at the issue price of $0.40.
This press release is not an offer to sell or the solicitation of an offer to buy the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements.
About Aptilon
Aptilon enables pharmaceutical, biotech, and medical device companies to effectively reach and interact with physicians via the Internet through its innovative live video detailing (with company reps), e-detailing, e-sampling, peer selling, and other educational content programs. Leading healthcare companies have adopted Aptilon's "Sales Force of the Future" model, driving tens of thousands of high-quality rep-physician interactions averaging 8 to 10 minutes in length. Aptilon provides the necessary infrastructure for sales representatives to build physician awareness, understanding, and preference during all stages of a product life cycle, from pre-launch education through to end-stage support. For more information, visit www.aptilon.com.
###
The TSX Venture Exchange Inc. has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
